HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,813-7,824 of 27,277
Drug study icon
CompletedNCT03365362

A study of Directly Observed and Long-term Varenicline

Official study title

Achieving Smoking Cessation Milestones in Opioid Treatment Patients: a Randomized 2 x 2 Factorial Trial of Directly Observed and Long-term Varenicline

This study has finished and is no longer accepting participants.

In The Bronx
AddictionMedication studyAges 18+
Countries
United States
Sponsor
Albert Einstein College of Medicine
Other study type icon
CompletedNCT02357173

A study of E-cigarettes in Current Cigarette Smokers

Official study title

A Trial of E-cigarettes: Natural Uptake, Patterns and Impact of Use

This study has finished and is no longer accepting participants.

In Charleston
AddictionInterventional studyAges 18+
Countries
United States
Sponsor
Medical University of South Carolina
Drug study icon
CompletedNCT05800860

A study of GH001 in people with Treatment-resistant Depression

What is this study about?

This study evaluated the safety and effectiveness of GH001 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Pilsen
DepressionMedication studyAges 18–64
Countries
Czechia, Germany, Ireland, + 3 others
Sponsor
GH Research Ireland Limited
Drug study icon
CompletedNCT05273567

A study of Guanfacine-er for Addiction

Official study title

A Randomized Controlled Trial of Guanfacine-er for Cannabis Use Disorder

This study has finished and is no longer accepting participants.

In New York
AddictionMedication studyAges 18–65
Countries
United States
Sponsor
New York State Psychiatric Institute
Drug study icon
TerminatedNCT02234011

A study of Intranasal Ketamine for OCD

Official study title

A Placebo-Controlled Crossover Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder

This study ended early.

In Belmont
OCDMedication studyAges 18–55
Countries
United States
Sponsor
Mclean Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT04030143

A study of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolarity type I

Official study title

A Phase 1b, Open-label, Multiple-dose, Randomized, Parallel-arm, Safety, Tolerability, and Pharmacokinetic Trial of Aripiprazole Intramuscular Depot Administered in the Gluteal Muscle in Adult Subjects With Schizophrenia or Bipolar I Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Bipolarity, SchizophreniaMedication studyAges 18–64
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00762268

SAMe supplement for treatment-resistant depression in bipolarity

About this title

A Trial of SAMe for Treatment-Resistant Bipolar Depression

Read the official source — NCT00762268
What is this study about?

Researchers compared SAMe and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

This study has finished and is no longer accepting participants.

In Belmont
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Mclean Hospital (Hospital / academic medical center)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.